Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-943-4 | CAS number: 598-63-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicosis Associated with Dual Oral Exposure of Rats to Lead and Trichloroethylene
- Author:
- Jack Nunes, Marion Ehrich and John Robertson
- Year:
- 2 001
- Bibliographic source:
- Toxicol Pathol. 2001 Jul-Aug; 29(4):451-7
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Adult male rats were exposed orally to lead carbonate (2,000 mg/kg) for 9 days. Potential neurotoxicity was evaluated by using the Functional Observational Battery (FOB) recommended for neurotoxicity screening. Rats were sacrificed on day 16, and brain, testes, spleen, kidney/adrenals, heart, and liver weighed and observed for pathological changes.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Lead carbonate
- EC Number:
- 209-943-4
- EC Name:
- Lead carbonate
- Cas Number:
- 598-63-0
- Molecular formula:
- CH2O3.Pb
- IUPAC Name:
- λ²-lead(2+) carbonate
- Details on test material:
- - Name of test material (as cited in study report): lead carbonate
- Analytical purity: 100 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague-Dawley, Indianapolis, Indiana
- Age at study initiation: 75 days old
- Weight at study initiation: 293 to 330 g
- Fasting period before study: 5 hr
- Housing: 2 per polycarbonate cage
- Diet: mouse/rat diet with 24 % protein, 4 % fat and 5 % crude fiber ad libitum
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- lead carbonate: 16 days
trichloroethylene (TCE): 7 days (after 9 days of corn oil only)
lead carbonate + TCE: TCE for 7 days after lead carbonate for 16 days - Frequency of treatment:
- daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2 mg/kg
Basis:
no data
- No. of animals per sex per dose:
- 10 rats/group
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and examinations performed and frequency:
- BODY WEIGHT: Yes
- Time schedule for examinations: during the FOBs (Functional Observational Battery)
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at sacrifice
- How many animals: 5 randomly chosen rats/group
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: prior to the initial dosing, on day 9 prior to onset of TCE dosing, and during the dark cycle prior to sacrificing the animals 16 days into the study
- Dose groups that were examined: rats were randomized
- Battery of functions tested: according to the FOB (Functional Observational Battery): activity, autonomic nervous system function, excitability, convulsions, neuromuscular function and sensorimotor function - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Results and discussion
Results of examinations
- Clinical signs:
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- only with lead carbonate alone or +TCE
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- only with lead carbonate alone or +TCE
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- effects observed, treatment-related
- Description (incidence and severity):
- only with lead carbonate alone or +TCE
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- only with lead carbonate alone or +TCE
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- only with lead carbonate alone or +TCE
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- with lead carbonate alone or +TCE or with TCE
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- BODY WEIGHT AND WEIGHT GAIN
Reduced body weight
HAEMATOLOGY
High blood lead levels
NEUROBEHAVIOUR
Decreases in grip strenght, foot splay, activity, alterations in ease of removing from the cage, piloerection, reaction to handling
ORGAN WEIGHTS
Reduced organ weights and significantly different organ-to-body weight ratios
GROSS PATHOLOGY
Marked decrease in testicular size, hemorhaging of the testicles, severely bloated stomachs, pale livers, absence of mesenteric fat
HISTOPATHOLOGY: NON-NEOPLASTIC
Increased incidence of chronic inflammation in the arterial wall of lungs, tubular cell inclusions, coagulated protein casts in tubular lumens, tubular dilation, vacuolization of periportal hepatocytes, increased incidence of single cell necrosis, gastritis, peritonitis
Effect levels
- Dose descriptor:
- NOAEL
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: Organ weights; histopathology
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Lead toxicity was noted on many parameters when the FOB was used for examination of treated rats. Signicant decreases in body weight, rectal temperature, grip strength, foot splay, and activity were measured. Alterations in ease of removing from the cage, piloerection, and reaction to handling were noted as the FOB was done.
There were no differences between rats given lead only and rats given lead plus trichloroethylene (TCE). TCE had little effect on
most parameters measured during the FOB, although weight was somewhat reduced and foot splay was increased. Weight was reduced more in rats given the lead plus TCE combination or lead only when compared to rats given TCE only.
Applicant's summary and conclusion
- Conclusions:
- Lead carbonate toxicity appears to be the cause of the majority of the toxic consequences seen in this study.
Even with similar target organs, concurrent administration of lead carbonate plus TCE did not cause synergistic or even additive effects
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.